Clinical Report: Single-Cell Scoring of Extracellular Vesicle Programs in IDD

Overview

This study identifies significant immunometabolic changes in mesenchymal stromal cells (MSCs) during intervertebral disc degeneration (IDD) through single-cell RNA sequencing. Key findings highlight the role of AP2S1 and CSTB as potential biomarkers linking MSC extracellular vesicle programs to immune signaling.

Background

Intervertebral disc degeneration (IDD) is a major contributor to low back pain, affecting millions globally and leading to substantial healthcare costs. Recent insights suggest that IDD is not solely a mechanical issue but involves complex immune and metabolic interactions. Understanding these processes may reveal new therapeutic targets for managing IDD.

Data Highlights

Key Findings

• Marked increase in EV-program scores in MSCs from IDD tissues.
• EV-score–high MSCs exhibit enhanced immune signaling and interaction potential.
• Identification of five hub genes linked to immune and metabolic pathways.
• Dynamic expression of AP2S1 and CSTB along MSC pseudotime trajectories.
• Hub-gene model effectively distinguishes IDD from control samples.

Clinical Implications

The findings suggest that targeting the identified hub genes, particularly AP2S1 and CSTB, may offer new avenues for therapeutic intervention in IDD. Understanding the immune and metabolic changes in MSCs could enhance treatment strategies for low back pain associated with disc degeneration.

Conclusion

This research elucidates the complex interplay between MSCs and immune signaling in IDD, highlighting potential biomarkers and therapeutic targets for future studies.

Related Resources & Content

1. Frontiers in Neurology, 2026 -- Integrating multi-omics and machine learning to explore the role of amino acid metabolism in intervertebral disk degeneration
2. npj Digital Medicine, 2026 -- Unraveling the Immunoregulatory Role of ERS–CAF Through Multimodal AI: Implications for Prognosis and Treatment Across Cancers
3. Frontiers in Cardiovascular Medicine, 2026 -- Cathepsin B ablation alleviates VSMC phenotypic switching by modulating alternative macrophage polarization through the NLRP3 signaling pathway
4. WHO guideline for non-surgical management of chronic primary low back pain in adults in primary and community care settings
5. Bone marrow concentrate intradiscal injection for chronic discogenic low back pain: A double-blind randomized sham-controlled trial - PubMed
6. Frontiers in Endocrinology — Cellular and molecular mechanisms of diabetes-mediated disc degeneration
7. Role of macrophage in intervertebral disc degeneration | Bone Research
8. WHO guideline for non-surgical management of chronic primary low back pain in adults in primary and community care settings
9. Bone marrow concentrate intradiscal injection for chronic discogenic low back pain: A double-blind randomized sham-controlled trial - PubMed